Australia's most trusted source of pharma news
Wednesday, 19 February 2020
Lost Your Access?
AZ's big win with lung listing
Imfinzi set to steal IO market from competitors.
iNova helps in fire recovery
Staff get paid leave to aid fire-affected communities.
Fresh talent in pharma comms
As some familiar faces exit for other industries.
Meds supply 'threat to security'
Defence experts warn of over-reliance on drug imports.
Chair change for MedAdvisor
Pharma app developer heads into new markets .
Top of the Hill
Where is Minister Hunt?
Health Minister is seemingly everywhere - and nowhere.
Epipen headache not over
Failure to 'a' flag competitors an issue says Health.
C-suite switches at Gilead, AZ
Top level movement as Novartis builds a new team.
Roche calls for new meds policy
Urgent need for change of direction as therapies change.
Yescarta wins MSAC nod
CAR-T gets green light but asking price slashed.
Which drugs will win in 2020?
PBS contests show some surprising new frontrunners.
Aust funds vaccine hunt
Minister puts up $2m for COVID-19 fight.
PBS king Eylea keeps growing
On top of brand table but not sitting still.
What will fill Lantus cavity?
Over 300,000 scripts to move as Sanofi phases it out.
CSL changes tack on tax law
R&D plan not ideal but need for 'regulatory certainty'.
Novartis ups Gilenya defence
Allowed to amend disputed blockbuster patent.
Will CAR-Ts break health budget?
Committee waves red flag as third CAR-T moves forward.
First copy of Sanofi drug
Potential blood thinner competitor.
Top of the Hill
Ghost of PBS Future hovers
Medicines funding like a 21st century Dickensian tale.
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design